Validea's guru fundamental report highlights Amgen (AMGN), a large-cap growth biotechnology stock, as its highest-rated pick using the Multi-Factor Investor model. Based on Pim van Vliet's strategy, which prioritizes low volatility, strong momentum, and high net payout yields, AMGN achieved an 81% rating, signifying "some interest" according to the model's criteria and aligning with the strategy's premise of superior returns from low-risk equities.
Amgen, Inc. (AMGN) has been identified by Validea's fundamental report as its highest-rated stock based on the Pim van Vliet Multi-Factor Investor model, achieving a score of 81%. This model specifically seeks large-cap, low-volatility stocks that also exhibit strong momentum and high net payout yields. AMGN's 81% score indicates a moderate level of interest from the strategy. The stock successfully passed the criteria for market capitalization and standard deviation, confirming its low-volatility profile, which is a central tenet of the van Vliet investment philosophy. However, the analysis presents a mixed picture, as AMGN received neutral ratings for its 'Twelve Minus One Momentum' and 'Net Payout Yield'. Critically, despite the high initial score, the stock received a 'FAIL' on its 'Final Rank', suggesting that while it meets some key characteristics, it does not satisfy the strategy's comprehensive requirements for a strong recommendation.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
